Simon Moore

Global Lead of Inhalation Science and Engineering at Covance

Simon Moore joined Envigo in 1999 as an inhalation study analyst and was promoted quickly within the Aerosol Technology and Analysis section. When the section expanded and divided in 2003 into inhalation chemistry and aerosol technology, Simon was promoted to the role of Head of Aerosol Technology with managerial responsibility for the aerosol technologists. In 2009, he took managerial responsibility for the inhalation engineering services group. In 2016, he was promoted to his current title. In July 2017, Simon took on the additional responsibility of being part of the Toxicology Operations Management as a Team Leader of the inhalation study management team with line management responsibility for Study Managers and Trainee Study Managers in the Inhalation Studies Group.

In November 2019, Simon took on the additional responsibility of the US Aerosol technology and is now the Global Lead of Inhalation Science and Engineering. He is responsible for all aerosol technology aspects including of the overall interpretation and reporting of the inhalation studies including safety pharmacology and ADME globally. The inhalation engineering services groups designs, prototypes and manufactures custom made inhalation equipment for all inhalation sites within the Covance organisation.

Simon obtained his degree from the University of Dundee in Chemistry (1996) and gained his PhD in Heterogeneous Catalysis from the University of Glasgow (2000) using high-pressure gas flow and chromatography. Simon lectures at the University of Surrey as part of the MSc Toxicology course on inhalation dosing, techniques and methodology, is the Vice Chairman of the Association of Inhalation Toxicologists, a committee member of the British Standard Institution on Nanotechnologies and has produced over 100 publications.

Simon_Moore_Covance_IRDD_BioTech_Pharma_Summit_Inhalation_respiratory_Drug_delivery_Profile

Use of 3d printing, Computational fluid dynamics and customised engineering in inhalation pre-clinical development

  • Learning Objectives
  • Applying novel 3d scanning and 3d printer
  • Designs that been assessed using computational fluid dynamics and ex vivo evaluation
  • Improving animal welfare and study conduct and integrity

 

 

 

Other Speakers from the IRDD Summit 2020

Peter Robbins

Professor of Physiology at the University of Oxford

Tonya Winders

President and CCEO of Allergy & Asthma Network

Wayland Rushing

Director, Scientific Affairs at Eurofins BioPharma